GlassScriptPhysician profile
Mark Andrew Miller
NPI 1265572093
$8,086.35
in general payments reported to CMS, 2019-2025
34 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $186 · 2021: $46.26 · 2022: $465 · 2023: $3,638 · 2024: $2,536 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,489 · Consulting Fee: $2,220 · Travel and Lodging: $1,036 · Entertainment: $18.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,489.38 |
| Consulting Fee | $2,220.00 |
| Travel and Lodging | $1,036.31 |
| Entertainment | $18.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,593.15 | 2021-2025 | Lynparza |
| Medical Device Business Services, INC. | $1,195.03 | 2024 | Enseal |
| Glaxosmithkline, LLC. | $588.44 | 2022-2025 | Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $497.28 | 2022-2025 | Keytruda, Lynparza, Lenvima |
| Intuitive Surgical, INC. | $434.00 | 2019-2023 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $302.13 | 2023-2025 | Myosure Tissue Removal Device, Novasure, Acessa Provu System |
| Astellas Pharma US INC | $269.69 | 2023-2025 | Veozah |
| Eisai INC. | $265.74 | 2022-2025 | |
| Ethicon US, LLC | $212.31 | 2022-2024 | Ethicon, Stratafix, Enseal X1 |
| Sumitomo Pharma America, INC. | $210.01 | 2023 | Myfembree |
| Baxter Healthcare | $201.84 | 2021-2025 | Tisseel, Adept |
| Sanara Medtech INC. | $186.39 | 2023-2024 | Celleraterx |
| Novo Nordisk INC | $168.41 | 2020 | |
| Pfizer INC. | $143.55 | 2023-2024 | |
| Amarin Pharma, INC. | $115.45 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $110.67 | 2024 | |
| Seagen INC. | $87.80 | 2023 | Tivdak |
| Smith+Nephew, INC. | $59.12 | 2020-2024 | Pico 7, Renasys Touch |
| Immunogen, INC. | $56.11 | 2023-2024 | Elahere, Elahere |
| Clovis Oncology, INC. | $56.06 | 2019 | |
| Aroa Biosurgery Incorporated | $55.87 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $43.24 | 2023 | Arista Ah Flexitip |
| Daiichi Sankyo INC. | $29.73 | 2025 | Enhertu |
| Coopersurgical, INC. | $25.77 | 2023 | Mara Console |
| Conmed Corporation | $25.36 | 2019-2023 | Airseal |
| Kerecis Limited | $24.72 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Tesaro, INC. | $21.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.67 | 2024 | Xarelto |
| Abbvie INC. | $19.24 | 2023 | |
| Medtronic, INC. | $18.75 | 2023 | Interstim |
| Provepharm INC. | $18.72 | 2024 | Bludigo |
| Myriad Genetic Laboratories, INC. | $14.98 | 2023 | Precisetumor |
| Exact Sciences Corporation | $14.47 | 2025 | Cologuard Collection Kit |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.